GNRH1 and metabolic disease: It seems that this still belongs to symptomatic treatment; while considering the central role of GnRH in PCOS pathogenesis, therapeutics targeting GnRH neurons can improve endocrine disorders, which further improves metabolic disorders and gut microbiota dysbiosis in PCOS.